Clinical Utility of F-18 Labeled Fibroblast Activation Protein Inhibitor (FAPI) for Primary Staging in Lung Adenocarcinoma: a Prospective Study

作者：Youcai Li, Xinqing Lin, Yi Li, Jie Lv, Peng Hou, Shaoyu Liu, Penghao Chen, Min Wang, Chengzhi Zhou, Xinlu Wang · 发表于：Molecular Imaging and Biology · 年份：2021 · DOI：10.1007/s11307-021-01679-w · 被引用次数：51 · 研究领域：Peptidase Inhibition and Analysis、Cardiac Structural Anomalies and Repair、Radiopharmaceutical Chemistry and Applications